Your prediction
Investigator Resources Ltd Stock
Investigator Resources Ltd took a tumble today and lost -€0.004 (-14.040%).
Pros and Cons of Investigator Resources Ltd in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Investigator Resources Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Investigator Resources Ltd | -14.040% | 7.143% | -19.643% | 104.545% | -74.138% | 2.273% | -43.750% |
| Strategic Energy Resources | 0.710% | -11.875% | -20.339% | 14000.000% | 14000.000% | 1181.818% | 166.038% |
| Black Ridge Mining Ltd | 12.500% | -11.111% | -7.692% | 700.000% | 1100.000% | 100.000% | 84.615% |
| Elementos Ltd | 3.680% | -6.863% | -13.636% | 230.435% | 13.772% | 206.452% | -10.588% |
News
Palvella Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Palvella Therapeutics, Inc.? Here are five stocks we like better.
- Palvella remains on track to submit its NDA for QTORIN rapamycin in microcystic lymphatic
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Key Points
- Interested in Turn Therapeutics Inc.? Here are five stocks we like better.
- Turn Therapeutics refined the stage two design of its GX-03 phase II eczema trial after an interim